• [stock-market-ticker symbols="AAPL;MSFT;GOOG;HPQ;^SPX;^DJI;LSE:BAG" stockExchange="NYSENasdaq" width"100%" palette="financial-light"]

    FDA Approves Hydroxychloroquine To Fight Chinavirus

    March 30, 2020
    No Comments

    Since the 1940s chloroquine has been used to treat the deadly disease of malaria caused by mosquito bites the infects over 200 million people every year. Recently the drug has been used in combination with other medications to alleviate the symptoms of Chinavirus (COVID-19). On Sunday the Food and Drug Administration issued an emergency authorization for hydroxychloroquine and chloroquine to be used for Chinavirus treatment.

    chloroquine
    chloroquine

    In recent weeks President Trump has cited the early success stories from France and New York where doctors have used chloroquine combined with drugs like azithromycin (Z-Pak) and zinc sulfate. Getting innovative treatments and remedies to mitigate or cure the symptoms of Chinavirus has been a top priority of virus response team. The estimated timeline for a broadly distributed vaccine to inoculate people from Chinavirus is a year and and a half away so alternative solutions are needed.

    Inexplicably, some Democrat governors have banned the sale of chloroquine in their states. Misinformation campaigns by Fake News media have questioned the effectiveness of the drug and ridiculed the President for suggesting it as a possible solution for some patients. Now, thanks to a rapid response by the FDA America and the world will test effectiveness on the drug on a large number of cases. As President Trump has said about the drug, "Let's see how it works." 

    SHARE THIS ARTICLE

    Author

    CDM Staff

    The mission at Creative Destruction Media is to be the catalyst for the "process of industrial mutation that incessantly revolutionizes the economic structure from within, incessantly destroying the old one, incessantly creating a new one."
  • Subscribe
    Notify of
    guest

    0 Comments
    Inline Feedbacks
    View all comments

    FOLLOW US

  • Subscribe to our evening newsletter to stay informed during these challenging times!!

    ×